Deckers Outdoor Corp. 10-K Summary (Fiscal Year Ended Dec 31, 1999)
Business Context and Reporting Period
This Annual Report on Form 10-K covers the fiscal year ended December 31, 1999. Deckers Outdoor Corporation designs and markets innovative, function-oriented footwear under three primary brands: Teva (sports sandals), Simple (casual footwear), and Ugg (sheepskin boots). The Company operates primarily through independent manufacturers in the Far East, Australia, and New Zealand, with no direct manufacturing facilities as of 1999.
Key Financial Metrics
| Metric | 1999 | 1998 | 1997 |
|---|---|---|---|
| Net Sales | $109,666,000 | $102,172,000 | $106,713,000 |
| Gross Profit | $45,128,000 | $36,580,000 | $44,260,000 |
| Gross Margin | 41.2% | 35.8% | 41.5% |
| Operating Earnings | $6,750,000 | ($2,798,000) | $8,112,000 |
| Net Earnings | $2,884,000 | ($2,907,000) | $4,524,000 |
| Cash from Operations | $18,209,000 | ($10,156,000) | $8,901,000 |
| Working Capital | $38,658,000 | $42,135,000 | $39,222,000 |
| Total Debt (Long-term + Current) | $6,401,000 | $21,435,000 | $17,983,000 |
| Cash and Equivalents | $1,633,000 | $263,000 | $3,238,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.3% to $109.7 million, driven by a 17.7% surge in Teva sales ($79.9 million) and an 11.3% increase in Ugg sales ($11.9 million). This offset a 23.1% decline in Simple sales due to a failed repositioning strategy.
- Profitability Recovery: The Company returned to profitability with $2.9 million in net earnings, reversing a $2.9 million net loss in 1998. Gross margin improved to 41.2% from 35.8%, aided by the absence of significant inventory write-downs and factory closure charges incurred in 1998.
- Debt Reduction: Total debt decreased significantly from $21.4 million in 1998 to $6.4 million in 1999, following the repayment of a supplier note and reduced borrowings under the credit facility.
- Inventory Management: Inventories decreased 23.5% to $18.1 million, reflecting improved sourcing and a shift in European fulfillment processes.
Guidance, Outlook, and Risks
- Outlook: Management expects Teva sales to be relatively flat in 2000, with domestic weakness offset by international expansion. Ugg sales are expected to continue increasing. Simple sales are projected to increase as the brand refocuses on the teen market. SG&A expenses are expected to decrease as a percentage of sales.
- Teva License: A new exclusive license with Mark Thatcher became effective Jan 1, 2000, running through 2004 with renewal options through 2011 contingent on meeting minimum sales levels. Failure to meet these levels could result in the loss of the Teva brand, which accounted for 72.9% of 1999 sales.
- Legal Contingencies: The Company is appealing a $1.785 million jury verdict from a 1999 trade secret lawsuit (Molly Strong-Butts). Management does not anticipate a material adverse effect.
- Customs Duties: The Company faces potential exposure of up to $500,000 in unpaid anti-dumping duties for 1997 imports into Europe from China. If enforced, future imports of certain Teva styles from China to Europe may become uneconomical.
- Year 2000: The Company believes it has achieved Y2K compliance but notes risks associated with suppliers and infrastructure.
Investor Verification Checklist
- Teva License Renewal: Verify the Company's ability to meet the minimum sales thresholds required to renew the Teva license beyond 2004.
- Simple Brand Turnaround: Monitor the success of the refocused marketing strategy for the Simple brand to ensure projected sales growth materializes.
- European Customs Resolution: Track the outcome of the dispute with Dutch Customs regarding anti-dumping duties and the impact on European margins.
- Legal Appeal Status: Confirm the status of the appeal regarding the $1.785 million Molly verdict.
- Debt Covenants: Ensure continued compliance with the tangible net worth covenant ($30 million) under the $50 million revolving credit facility.